Megna Michael R sold KNSA
October 20, 2025 · Form 4 insider transaction
Megna Michael R sold 13,235 shares of Kiniksa Pharmaceuticals International, plc at $39.31 per share, a transaction worth $520.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
13,235
Price
$39.31
Total value
$520.3K
InsiderMegna Michael R
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateOctober 20, 2025
Filing dateOctober 22, 2025
Shares owned after27,046
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on May 24, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.145 and $39.57. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.